TY  - GEN
AU  - Hiramatsu,Naoki
AU  - Kurosaki,Masayuki
AU  - Sakamoto,Naoya
AU  - Iwasaki,Manabu
AU  - Sakamoto,Minoru
AU  - Suzuki,Yoshiyuki
AU  - Sugauchi,Fuminaka
AU  - Tamori,Akihiro
AU  - Kakinnuma,Sei
AU  - Matsuura,Kentaro
AU  - Izumi,Namiki
TI  - Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis
SN  - 1435-5922
PY  - 2012///0113
KW  - Adult
KW  - Aged
KW  - Anemia, Hemolytic
KW  - chemically induced
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Cohort Studies
KW  - Decision Trees
KW  - Disease Progression
KW  - Dose-Response Relationship, Drug
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Male
KW  - Middle Aged
KW  - Polyethylene Glycols
KW  - Recombinant Proteins
KW  - Reproducibility of Results
KW  - Retrospective Studies
KW  - Ribavirin
KW  - Severity of Illness Index
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
UR  - https://doi.org/10.1007/s00535-011-0412-z
ER  -